Contact FreedomWorks

400 North Capitol Street, NW
Suite 765
Washington, DC 20001

  • Toll Free 1.888.564.6273
  • Local 202.783.3870
Capitol Comment 171 - Free Trade: Fast Track to Prosperity
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 171 - Free Trade: Fast Track to Prosperity

On September 16, President Clinton finally introduced his legislative proposal for renewing fast track authority to negotiate trade agreements. This authority, which expired in 1994, would allow the president to negotiate trade pacts that Congress must approve or disapprove by a simple up or down vote. Therefore, members of Congress — and the special interests who attempt to influence them — could not amend trade agreements during the legislative process.

10/13/1997
Capitol Comment 167 - EPA Ups Expected Cost of Air Quality Standards to $46 Billion
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 167 - EPA Ups Expected Cost of Air Quality Standards to $46 Billion

In April, the Environmental Protection Agency (EPA) admitted that it overestimated the benefits from the new air quality standard for fine particulate matter, lowering its estimates of annual reduced premature mortality from 20,000 to 15,000. Now the EPA says implementing the standards will cost more than its original estimate of $8.5 billion annually; its final Regulatory Impact Analysis (RIA) for the new standards contains an annual cost estimate of $46 billion.1

08/27/1997
Capitol Comment 162 - Risky Business: Insurance, Risk Classification and the Consumer
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 162 - Risky Business: Insurance, Risk Classification and the Consumer

Legislators and regulators increasingly are attempting to improve the availability and affordability of insurance -- whether life, health, auto or home -- by restricting how insurance companies can classify risks. However, those who attempt to reform insurance markets by restricting risk classification need to be very careful, for when they undermine the fundamental principles of risk-based insurance, they usually end up doing more harm than good.

06/25/1997
Capitol Comment 161 - The Senate and House Kiddycare Schemes Are a Bad Deal for Kids
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 161 - The Senate and House Kiddycare Schemes Are a Bad Deal for Kids

Parents had better put the kids to bed early this week. Otherwise, youngsters might happen across C-SPAN in time to watch the United States Senate and House of Representatives cast their most damaging votes ever against children's health. Armed with faulty data on the status of children's health coverage, Congress is set to spend $16 billion or more over the next five years to create a new federal "Kiddycare" program. While claiming to provide health coverage for children, Kiddycare will actually waste billions of dollars, and provide no health benefit to children.

06/24/1997
Capitol Comment 160 - Can You Differentiate a Taxpayer From a Consumer at the Grocery Store?
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 160 - Can You Differentiate a Taxpayer From a Consumer at the Grocery Store?

The federal sugar program fixes the price of sugar bought in the United States at roughly double the world price, costing consumers 1.4 billion dollars a year.1 Yet, program supporters claim the program does not hurt Americans, pointing to the small budget cost to the taxpayer. The distinction between a taxpayer and a consumer is a curious one -- since the two cannot be distinguished at the checkout line. In fact, consumers are hit twice by the program. First, with higher taxes -- regardless of how "small" the burden is -- and second through higher prices for the food they purchase.

06/13/1997
Capitol Comment 159 - Why America Should Renew MFN for China
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 159 - Why America Should Renew MFN for China

Members of Congress will soon be asked to vote on the unconditional extension of China's most-favored-nation (MFN) trading status for one more year. Legitimate reasons for concern over various policies implemented by the Chinese government do exist. However, revoking China's MFN trading status is at best the least effective -- and at worst the most counter-productive -- manner in which to affect those policies. It would be devastating for both Americans and the Chinese if Congress imposes trade barriers between the citizens of these two countries.

06/12/1997
Capitol Comment 158 - Cox-Wyden Putting Internet Taxation on Hold
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 158 - Cox-Wyden Putting Internet Taxation on Hold

The promise shown by the emergence of electronic commerce has attracted some undesirable attention - taxes. States and localities have recently been examining an extension of their tax authority to Internet related activities. The result could be a maze of multiple taxation that stymies emerging commercial activity.

05/22/1997
Capitol Comment 154 - FDA User Fees Have Done Nothing for Patients
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 154 - FDA User Fees Have Done Nothing for Patients

Summary: The FDA and the pharmaceutical industry are lobbying Congress heavily to reauthorize the 1992 Prescription Drug User Fee Act (PDUFA). Rather than bow to the will of industry or government bureaucrats, Congress should do what is best for patients: reform the FDA and give user fees the study they deserve.

03/19/1997
Capitol Comment 157 - The Case Against OPIC
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 157 - The Case Against OPIC

"I cannot see any redeeming aspect in the existence of OPIC. It is special interest legislation of the worst kind, legislation that makes the problem it is intended to deal with worse rather than better ... OPIC has no business existing." -- Nobel laureate Milton Friedman September 5, 1996

03/16/1997
Capitol Comment 149 - Aspirin Fights Heart Attacks, and the FDA Fights to Hide That Information from Your Doctor
null
http://d7.freedomworks.org.s3.amazonaws.com/styles/thumbnail/s3/te_social_media_share/fw_default_0.jpg?itok=mX_C44GW
Capitol Comment

Capitol Comment 149 - Aspirin Fights Heart Attacks, and the FDA Fights to Hide That Information from Your Doctor

11/12/1996

Pages